This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: James Even Voss: Innovator in B Cell Receptor Modification
Introduction
James Even Voss is a prominent inventor based in San Diego, California. He has made significant contributions to the field of immunology, particularly in the modification of B cell receptors. His innovative work aims to enhance the immune response against various pathogens.
Latest Patents
James Even Voss holds a patent for "B cell receptor modification in B cells." This patent describes methods and systems for generating engineered B cells with modified immunoglobulin genes. The modified immunoglobulin genes encode modified immunoglobulins that can exhibit high affinity for antigens. This includes antigens that are variable, such as those found on various pathogens that can evade mammalian immune responses. He has 1 patent to his name.
Career Highlights
Voss is affiliated with The Scripps Research Institute, where he conducts his research and development. His work is pivotal in advancing our understanding of immune responses and developing potential therapeutic strategies.
Collaborations
Some of his notable coworkers include Raiees Andrabi and Dennis R Burton. Their collaborative efforts contribute to the innovative research environment at The Scripps Research Institute.
Conclusion
James Even Voss is a key figure in the field of immunology, with a focus on B cell receptor modification. His contributions are essential for developing new strategies to combat infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile